The Use of Ruxolitinib for Improved Disease Control in Systemic Juvenile Idiopathic Arthritis (sJIA) and Recurrent Macrophage Activation Syndrome (MAS)

被引:0
|
作者
Collins, Kathleen [1 ]
Abutineh, Iman [1 ]
Paul, Trisha [2 ]
Rai, Parul [2 ]
Schulert, Grant [3 ]
Hines, Melissa [2 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Memphis, TN USA
[3] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0348
引用
收藏
页码:682 / 684
页数:3
相关论文
共 50 条
  • [1] Risk Score of Macrophage Activation Syndrome (MAS) in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA)
    Carbogno, Simone
    Marafon, Denise Pires
    Marucci, Giulia
    Sacco, Emanuela
    Pardeo, Manuela
    Alsaleem, Alhanouf
    Fingerhutova, Sarka
    Demir, Ferhat
    Cekada, Nastasia
    Kostik, Mikhail
    Kessel, Christoph
    Vougiouka, Olga
    Gagro, Alenka
    Tibaldi, Jessica
    Minoia, Francesca
    Maccora, Ilaria
    Schneider, Rayfel
    Dolezalova, Pavla
    Sozeri, Betul
    Jelusic, Marija
    Insalaco, Antonella
    De Benedetti, Fabrizio
    Bracaglia, Claudia
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [2] Biomarkers for the Diagnosis and the Identification of Risk of Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA)
    Bracaglia, Claudia
    Marafon, Denise Pires
    Caiello, Ivan
    de Graaf, Kathy
    Ballabio, Maria
    Ferlin, Walter
    Davi, Sergio
    Schulert, Grant
    Ravelli, Angelo
    Grom, Alexei A.
    Nelson, Robert
    de Min, Cristina
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Prolonged Fever in a Pediatric Patient: A Case of Systemic Juvenile Idiopathic Arthritis (sJIA) Complicated by Macrophage Activation Syndrome (MAS)
    Cortes, Marianne
    Nudelman, Brian G.
    Rouse, Megan J.
    Frost, Maria D.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [4] ARDS as a pulmonary Complication in an Adolescent with Macrophage Activation Syndrome (MAS) in the Context of an Initial Manifestation of systemic juvenile idiopathic Arthritis (sJIA)
    Ebner, K.
    Peitz, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 88 - 88
  • [5] Yang and Ying of ruxolitinib administration for macrophage activation syndrome complicated by systemic juvenile idiopathic arthritis
    Irabu, Hitoshi
    Kaneko, Shuya
    Miyaoka, Futaba
    Tomomasa, Dan
    Shimbo, Asami
    Nishimura, Akira
    Kamiya, Takahiro
    Isoda, Takeshi
    Kanegane, Hirokazu
    Shimizu, Masaki
    RHEUMATOLOGY, 2024,
  • [6] Emapalumab (Anti-Interferon-Gamma Monoclonal Antibody) in Patients with Macrophage Activation Syndrome (MAS) Complicating Systemic Juvenile Idiopathic Arthritis (sJIA)
    De Benedetti, Fabrizio
    Brogan, Paul
    Bracaglia, Claudia
    Pardeo, Manuela
    Marucci, Giulia
    Sacco, Emanuela
    Eleftheriou, Despina
    Papadopoulou, Charalampia
    Grom, Alexei
    Quartier, Pierre
    Schneider, Rayfel
    Jacqmin, Philippe
    Frederiksen, Rikke
    Ballabio, Maria
    de Min, Cristina
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 14 - 16
  • [7] EMAPALUMAB (ANTI-INTERFERON-GAMMA MONOCLONAL ANTIBODY) IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
    De Benedetti, F.
    Brogan, P.
    Bracaglia, C.
    Pardeo, M.
    Marucci, G.
    Sacco, E.
    Eleftheriou, D.
    Papadopoulou, C.
    Grom, A.
    Quartier, P.
    Schneider, R.
    Jacqmin, P.
    Frederiksen, R.
    Ballabio, M.
    De Min, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 180 - 180
  • [8] EMAPALUMAB (AN INTERFERON GAMMA (IFNY)-BLOCKING MONOCLONAL ANTIBODY) IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
    De Benedetti, Fabrizio
    Brogan, Paul
    Bracaglia, Claudia
    Pardeo, Manuela
    Marucci, Giulia
    Sacco, Emanuela
    Eleftheriou, Despina
    Papadopoulou, Charalampia
    Grom, Alexei
    Quartier, Pierre
    Schneider, Rayfel
    Jacqmin, Philippe
    De Graaf, Kathy
    Ballabio, Maria
    de Min, Cristina
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S7 - S8
  • [9] Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA): Treatment with Emapalumab, an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody
    De Benedetti, Fabrizio
    Grom, Alexei A.
    Brogan, Paul
    Bracaglia, Claudia
    Pardeo, Manuela
    Marucci, Giulia
    Eleftheriou, Despina
    Papadopoulou, Charalampia
    Quartier, Pierre
    Anton, Jordi
    Frederiksen, Rikke
    Asnaghi, Veronica
    Ballabio, Mari
    Min, Cristinade
    BLOOD, 2021, 138
  • [10] Macrophage activation syndrome in systemic juvenile idiopathic arthritis
    Shimizu, Masaki
    IMMUNOLOGICAL MEDICINE, 2021, 44 (04) : 237 - 245